Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18653228

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2008 Aug 9
First author
Motzer RJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2008 Aug 9;372(9637):427-9. doi: 10.1016/S0140-6736(08)61040-5.
    note
    Source null
    related pmid
    18653227
    relationship
    Comment in
  2. citation
    Eur Urol. 2009 Jun;55(6):1484-5. doi: 10.1016/j.eururo.2009.03.035.
    note
    Source null
    related pmid
    19650216
    relationship
    Comment in
  3. citation
    Eur Urol. 2009 Jun;55(6):1482-4. doi: 10.1016/j.eururo.2009.03.034.
    note
    Source null
    related pmid
    19650239
    relationship
    Comment in

Authors and identifiers

  1. name
    Motzer RJ
    type
    Author
  2. name
    Escudier B
    type
    Author
  3. name
    Oudard S
    type
    Author
  4. name
    Hutson TE
    type
    Author
  5. name
    Porta C
    type
    Author
  6. name
    Bracarda S
    type
    Author
  7. name
    Grünwald V
    type
    Author
  8. name
    Thompson JA
    type
    Author
  9. name
    Figlin RA
    type
    Author
  10. name
    Hollaender N
    type
    Author
  11. name
    Urbanowitz G
    type
    Author
  12. name
    Berg WJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Motzer RJ
    type
    Author
  2. name
    Escudier B
    type
    Author
  3. name
    Oudard S
    type
    Author
  4. name
    Hutson TE
    type
    Author
  5. name
    Porta C
    type
    Author
  6. name
    Bracarda S
    type
    Author
  7. name
    Grünwald V
    type
    Author
  8. name
    Thompson JA
    type
    Author
  9. name
    Figlin RA
    type
    Author
  10. name
    Hollaender N
    type
    Author
  11. name
    Urbanowitz G
    type
    Author
  12. name
    Berg WJ
    type
    Author
bibliography ids
  1. nci-bib-f4db1406b526e95705e68632
book metadata
content sha256
52c2a029dfdec47055b06f45676067e8ad75666fb7fdc688e9ccdc8bfdabcfe3
document type
citation
dois
  1. 10.1016/S0140-6736(08)61039-9
electronic publication date
display
2008 Jul 22
precision
day
year
2008
evidence scope
bibliographic_metadata_only
id
pubmed:18653228
immutable id
pubmed:18653228@52c2a029dfdec47055b06f45676067e8ad75666fb7fdc688e9ccdc8bfdabcfe3
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9637
name
Lancet (London, England)
nlm unique id
2985213R
pages
449-56
volume
372
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2008 Aug 9;372(9637):427-9. doi: 10.1016/S0140-6736(08)61040-5.
    note
    Source null
    related pmid
    18653227
    relationship
    Comment in
  2. citation
    Eur Urol. 2009 Jun;55(6):1484-5. doi: 10.1016/j.eururo.2009.03.035.
    note
    Source null
    related pmid
    19650216
    relationship
    Comment in
  3. citation
    Eur Urol. 2009 Jun;55(6):1482-4. doi: 10.1016/j.eururo.2009.03.034.
    note
    Source null
    related pmid
    19650239
    relationship
    Comment in
outcomes validated
false
pmid
18653228
provenance
batch id
6281e3e555c9a831cffc
provider
NCBI PubMed ESummary
record sha256
0b4b04bbbc51caf6b1dc507ac83180ddb0309b0b0abcf7a52f3ecd3fb3819cdd
response sha256
0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
retrieved at
2026-09-09T23:46:21.772457+00:00
publication date
display
2008 Aug 9
precision
day
year
2008
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18653228/
title
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

Preserved source evidence · Not medical advice